Skip to content
Recall Observatory FDA recall evidence

Drug product

Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

D-0505-2024

May 10, 2024

Class II

Product summary

Firm
Preferred Pharmaceuticals, Inc.
Event
Event 94648
Status
Ongoing
Classification
Class II
Quantity
66 bottles of 30 tablets
Official record key
drug-enforcement:D-0505-2024

Official wording

Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Code information: Lot #: J2022G, Exp: 01/01/2025

Distribution pattern: Product distributed to CA, FL, OK, KS and CT

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-nitroso-duloxetine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations